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Abstract
While disparity in pancreatic cancer incidence between blacks and whites has 
been observed, few studies have examined disparity in other ethnic minorities. 
We evaluated variations in pancreatic cancer incidence and assessed the extent to 
which known risk factors account for differences in pancreatic cancer risk among 
African Americans, Native Hawaiians, Japanese Americans, Latino Americans, and 
European Americans in the Multiethnic Cohort Study. Risk factor data were obtained 
from the baseline questionnaire. Cox regression was used to estimate the relative 
risks (RRs) and 95% confidence intervals (CIs) for pancreatic cancer associated with 
risk factors and ethnicity. During an average 16.9‐year follow‐up, 1,532 incident 
pancreatic cancer cases were identified among 184,559 at‐risk participants. Family 
history of pancreatic cancer (RR 1.97, 95% CI 1.50‐2.58), diabetes (RR 1.32, 95% 
CI 1.14‐1.54), body mass index ≥30 kg/m2 (RR 1.25, 95% CI 1.08‐1.46), current 
smoking (<20 pack‐years RR 1.43, 95% CI 1.19‐1.73; ≥20 pack‐years RR 1.76, 95% 
CI 1.46‐2.12), and red meat intake (RR 1.17, 95% CI 1.00‐1.36) were associated 
with pancreatic cancer. After adjustment for these risk factors, Native Hawaiians 
(RR 1.60, 95% CI 1.30‐1.98), Japanese Americans (RR 1.33, 95% CI 1.15‐1.54), 
and African Americans (RR 1.20, 95% CI 1.01‐1.42), but not Latino Americans (RR 
0.90, 95% CI 0.76‐1.07), had a higher risk of pancreatic cancer compared to European 
Americans. Interethnic differences in pancreatic cancer risk are not fully explained 
by differences in the distribution of known risk factors. The greater risks in Native 
Hawaiians and Japanese Americans are new findings and elucidating the causes of 
these high rates may improve our understanding and prevention of pancreatic cancer.
K E Y W O R D S
cohort, epidemiology, ethnicity, incidence, minority, pancreatic cancer
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1 |  INTRODUCTION
Pancreatic cancer is one of the deadliest malignancies in the 
United States. It has a 5‐year survival rate of only 8% and 
is the third most common cancer‐related death among men 
and women.1 By 2030, pancreatic cancer is estimated to sur-
pass colorectal cancer to become the second leading cause of 
cancer mortality.2 Given these circumstances, a better under-
standing of its risk factors is imperative for preventing pan-
creatic cancer occurrence.
Ethnic differences in pancreatic cancer incidence have 
been investigated in several previous settings.3 Most prior 
literature has focused on the higher rates of pancreatic can-
cer in African Americans compared to whites,4,5 with some 
research suggesting that this disparity may be partially ex-
plained by the greater prevalence of smoking, diabetes, and 
obesity among African Americans.4,6 However, only a few 
studies have assessed other ethnic minorities, which have ob-
served that Hispanics and Asians/Pacific Islanders have lower 
incidence rates of pancreatic cancer compared to whites and 
African Americans.7,8 Additionally, no previous study has 
closely evaluated the relationships between known risk fac-
tors and pancreatic cancer across multiple ethnic minorities. 
Thus, there is limited information as to whether risk factors 
identified in past literature explain varying degrees of pancre-
atic cancer incidence between racial/ethnic subpopulations.
The purpose of this study was to investigate differences 
in pancreatic cancer incidence across African Americans, 
Native Hawaiians, Japanese Americans, Latino Americans, 
and European Americans in the Multiethnic Cohort (MEC). 
In particular, we sought to assess the extent to which known 
risk factors account for these potential differences and 
whether the influence of specific risk factors varies by race/
ethnicity. Understanding these differences may allow us to 
better elucidate pancreatic cancer etiology across ethnic 
groups and establish more targeted prevention strategies.
2 |  METHODS
2.1 | Study population
The MEC was established in 1993‐1996 to investigate 
cancer etiology. It is comprised of >215,000 participants 
aged 45‐75 at entry recruited from Los Angeles County 
and Hawaii. The five main ethnic groups are European 
American, African American, Latino American, Japanese 
American, and Native Hawaiian.9 All participants com-
pleted a self‐administered baseline questionnaire, which 
included information on demographics, medical con-
ditions, family history of cancer, and lifestyle factors. 
Individuals were excluded from this study if they were not 
in the five main race/ethnicity groups (n = 13,987), had a 
prior pancreatic cancer diagnosis (n = 56), or were missing 
information on diet, diabetes, body mass index (BMI), and 
smoking (n = 12,957). Smokers with missing pack‐years 
data were further excluded (n = 4,091).
2.2 | Exposure assessment
Exposure information was obtained from the baseline 
questionnaire. Participants were asked to self‐report their 
race/ethnicity, height, weight, diabetes history, family his-
tory of cancer (first‐degree relative), and frequency and 
duration of cigarette smoking. Smoking was evaluated as 
overall status (never, past, current) and with pack‐year in-
formation (never, past with <20 pack‐years, past with ≥20 
pack‐years, current with <20 pack‐years, current with ≥20 
pack‐years). Height and weight measurements were used 
to calculate BMI (kg/m2). Alcohol  use (g/day) and  red 
meat (processed and nonprocessed) intake  (g/kcal/day) 
in the year prior to cohort entry were assessed through a 
food frequency questionnaire validated for a multiethnic 
population.10
2.3 | Outcome
Participants were followed from cohort entry to pancreatic 
cancer diagnosis, death, or end of follow‐up (31 December 
2013). Annual linkages with the statewide Surveillance, 
Epidemiology and End Results (SEER) registries of Hawaii 
and California were used to identify incident cases of pancre-
atic cancer (ICD‐O‐3 codes C25.0‐C29.9). Death dates for 
right‐censoring were ascertained using linkages with death 
certificate files for Hawaii and California and the National 
Death Index.
2.4 | Statistical analyses
Pancreatic cancer incidence rates, left truncated at age 45 and 
age‐standardized using the United States 2000 standard popu-
lation, were calculated for each race/ethnicity group. Race/
ethnicity‐specific incidence rates were compared to the inci-
dence rates for European Americans by testing the standard-
ized rate ratios. Cox models with time since cohort entry as the 
time metric were used to assess the influence of race/ethnicity 
and risk factors on pancreatic cancer incidence. Minimally ad-
justed models, with age and sex as strata variables and race/
ethnicity as a covariate, were fitted for each exposure. We 
also ran fully adjusted models which included age and sex as 
strata variables and race/ethnicity, family history of pancre-
atic cancer, diabetes, BMI (<25, 25‐30, ≥30 kg/m2), smoking 
with pack‐year information (never, past with <20 pack‐years, 
past with ≥20 pack‐years, current with <20 pack‐years, cur-
rent with ≥20 pack‐years), alcohol use (none, <24, 24‐48, 
>48 g/day), and red meat intake (examined as quartiles) as 
3594 |   HUANG et Al.
T
A
B
L
E
 1
 
Ba
se
lin
e c
ha
ra
cte
ris
tic
s o
f M
ul
tie
th
ni
c C
oh
or
t S
tu
dy
 pa
rti
cip
an
ts 
fro
m
 19
93
 to
 20
13
Ch
ar
ac
ter
ist
ic
To
ta
l (
N 
= 
18
4,5
59
)
Eu
ro
pe
an
 A
m
er
ica
n 
(N
 =
 46
,35
6)
Af
ric
an
 A
m
er
ica
n 
(N
 =
 30
,73
1)
Na
tiv
e H
aw
aii
an
 
(N
 =
 13
,41
2)
Ja
pa
ne
se
 A
m
er
ica
n 
(N
 =
 53
,42
9)
La
tin
o A
m
er
ica
n 
(N
 =
 40
,63
1)
N
%
N
%
N
%
N
%
N
%
N
%
Ag
e a
t b
as
eli
ne
 (y
)a
59
.9 
(8
.8)
58
.9 
(9
.1)
61
.0 
(9
.0)
56
.4 
(8
.6)
61
.0 
(9
.1)
59
.7 
(7
.8)
Ag
e g
ro
up
 at
 ba
se
lin
e
<5
0
31
,09
5
16
.9
9,4
54
20
.4
4,4
52
14
.5
3,7
91
28
.3
8,4
38
15
.8
4,9
60
12
.2
50
‐5
4
27
,67
3
15
.0
7,9
38
17
.1
4,2
83
13
.9
2,6
83
20
.0
7,0
40
13
.2
5,7
29
14
.1
55
‐5
9
29
,37
0
15
.9
6,9
85
15
.1
4,5
48
14
.8
2,1
10
15
.7
6,7
94
12
.7
8,9
33
22
.0
60
‐6
4
31
,74
4
17
.2
7,1
44
15
.4
4,2
96
14
.0
1,9
61
14
.6
8,8
92
16
.6
9,4
51
23
.3
65
‐6
9
32
,40
9
17
.6
7,1
90
15
.5
6,3
66
20
.7
1,6
01
11
.9
10
,61
4
19
.9
6,6
38
16
.3
≥7
0
32
,26
8
17
.5
7,6
45
16
.5
6,7
86
22
.1
1,2
66
9.4
11
,65
1
21
.8
4,9
20
12
.1
Se
x M
ale
83
,59
0
45
.3
21
,43
4
46
.2
11
,23
5
36
.6
5,8
83
43
.9
25
,33
6
47
.4
19
,70
2
48
.5
Fe
m
ale
10
0,9
69
54
.7
24
,92
2
53
.8
19
,49
6
63
.4
7,5
29
56
.1
28
,09
3
52
.6
20
,92
9
51
.5
Fa
m
ily
 hi
sto
ry
 of
 pa
nc
re
-
ati
c c
an
ce
r
3,1
75
1.7
80
0
1.7
35
7
1.2
19
7
1.5
1,2
50
2.3
57
1
1.4
Di
ab
ete
s
21
,56
3
11
.7
2,7
41
5.9
4,8
22
15
.7
1,9
88
14
.8
5,6
26
10
.5
6,3
86
15
.7
Bo
dy
 m
as
s i
nd
ex
 (k
g/
m2
)
<2
5
76
,97
3
41
.7
21
,35
6
46
.1
8,2
95
27
.0
3,5
78
26
.7
32
,20
8
60
.3
11
,53
6
28
.4
25
‐3
0
70
,86
5
38
.4
16
,85
4
36
.4
12
,58
0
40
.9
5,0
37
37
.6
17
,47
1
32
.7
18
,92
3
46
.6
≥3
0
36
,72
1
19
.9
8,1
46
17
.6
9,8
56
32
.1
4,7
97
35
.8
3,7
50
7.0
10
,17
2
25
.0
Sm
ok
in
g s
tat
us
Ne
ve
r
82
,85
2
44
.9
18
,22
9
39
.3
11
,91
0
38
.8
5,3
05
39
.6
26
,99
1
50
.5
20
,41
7
50
.2
Pa
st
72
,08
6
39
.1
20
,49
9
44
.2
11
,90
7
38
.8
5,0
82
37
.9
20
,15
2
37
.7
14
,44
6
35
.6
Cu
rre
nt
29
,62
1
16
.1
7,6
28
16
.5
6,9
14
22
.5
3,0
25
22
.6
6,2
86
11
.8
5,7
68
14
.2
Pa
ck
‐y
ea
rsa
10
.2 
(1
5.0
)
13
.5 
(1
7.6
)
10
.0 
(1
3.4
)
12
.2 
(1
5.8
)
9.8
 (1
4.8
)
6.4
 (1
1.5
)
Sm
ok
in
g s
tat
us
, w
ith
 pa
ck
‐y
ea
r i
nf
or
m
ati
on
Ne
ve
r
82
,85
2
44
.9
18
,22
9
39
.3
11
,91
0
38
.8
5,3
05
39
.6
26
,99
1
50
.5
20
,41
7
50
.3
Pa
st 
<2
0 p
ac
k‐
ye
ar
s
53
,37
0
28
.9
13
,70
2
29
.6
9,4
31
30
.7
3,6
48
27
.2
14
,25
3
26
.7
12
,33
6
30
.4
Pa
st 
≥2
0 p
ac
k‐
ye
ar
s
18
,71
6
10
.1
6,7
97
14
.7
2,4
76
8.1
1,4
34
10
.7
5,8
99
11
.0
2,1
10
5.2
Cu
rre
nt
 <
20
 
pa
ck
‐y
ea
rs
15
,96
0
8.7
2,7
78
6.0
4,5
28
14
.7
1,5
56
11
.6
3,0
06
5.6
4,0
92
10
.1
(C
on
tin
ue
s)
   | 3595HUANG et Al.
Ch
ar
ac
ter
ist
ic
To
ta
l (
N 
= 
18
4,5
59
)
Eu
ro
pe
an
 A
m
er
ica
n 
(N
 =
 46
,35
6)
Af
ric
an
 A
m
er
ica
n 
(N
 =
 30
,73
1)
Na
tiv
e H
aw
aii
an
 
(N
 =
 13
,41
2)
Ja
pa
ne
se
 A
m
er
ica
n 
(N
 =
 53
,42
9)
La
tin
o A
m
er
ica
n 
(N
 =
 40
,63
1)
N
%
N
%
N
%
N
%
N
%
N
%
Cu
rre
nt
 ≥
20
 
pa
ck
‐y
ea
rs
13
,66
1
7.4
4,8
50
10
.5
2,3
86
7.8
1,4
69
11
.0
3,2
80
6.1
1,6
76
4.1
Al
co
ho
l u
se
 (g
/d
ay
)
No
ne
94
,44
6
51
.2
16
,12
4
34
.8
17
,18
7
55
.9
7,1
97
53
.7
33
,28
0
62
.3
20
,65
8
50
.8
<2
4
69
,00
9
37
.4
21
,37
9
46
.1
10
,85
8
35
.3
4,7
31
35
.3
15
,71
5
29
.4
16
,32
6
40
.2
24
‐4
8
13
,15
8
7.1
5,5
73
12
.0
1,5
39
5.0
91
2
6.8
3,0
15
5.6
2,1
19
5.2
>4
8
7,9
46
4.3
3,2
80
7.1
1,1
47
3.7
57
2
4.3
1,4
19
2.7
1,5
28
3.8
Re
d m
ea
t i
nt
ak
e (
g/
kc
al/
da
y)
Q1
 (0
‐1
4.1
)
46
,14
0
25
.0
14
,90
3
32
.1
7,6
81
25
.0
2,1
81
16
.3
13
,05
1
24
.4
8,3
24
20
.5
Q2
 (1
4.1
‐2
3.9
)
46
,13
9
25
.0
12
,03
8
26
.0
7,1
86
23
.4
3,0
61
22
.8
14
,33
5
26
.8
9,5
19
23
.4
Q3
 (2
3.9
‐3
5.2
)
46
,14
0
25
.0
10
,42
8
22
.5
7,2
82
23
.7
3,8
09
28
.4
14
,35
0
26
.9
10
,27
1
25
.3
Q4
 (3
5.2
‐2
16
.5)
46
,14
0
25
.0
8,9
87
19
.4
8,5
82
27
.9
4,3
61
32
.5
11
,69
3
21
.9
12
,51
7
30
.8
Ed
uc
ati
on
≤1
2 y
79
,97
8
43
.3
12
,14
9
26
.2
12
,31
2
40
.1
7,0
34
52
.5
21
,17
3
39
.6
27
,31
0
67
.2
So
m
e c
ol
leg
e/
vo
ca
tio
na
l
54
,49
9
29
.5
14
,58
4
31
.5
11
,36
3
37
.0
4,0
00
29
.8
15
,78
1
29
.5
8,7
71
21
.6
Co
lle
ge
 gr
ad
ua
te
49
,31
1
26
.7
19
,53
7
42
.1
6,9
19
22
.5
2,3
44
17
.5
16
,34
4
30
.6
4,1
67
10
.3
M
iss
in
g
77
1
0.4
86
0.2
13
7
0.5
34
0.3
13
1
0.3
38
3
0.9
Al
l t
es
ts 
co
m
pa
rin
g d
ist
rib
ut
io
n o
f r
isk
 fa
cto
rs 
ac
ro
ss
 ra
ce
/et
hn
ici
ty
 gr
ou
ps
 ha
d P
 <
 0.
00
01
.
a M
ea
n (
sta
nd
ar
d d
ev
iat
io
n)
. 
T
A
B
L
E
 1
 
(C
on
tin
ue
d)
3596 |   HUANG et Al.
covariates. Trends were examined using a model that treated 
the exposure as a continuous variable coded as consecutive 
numbers (eg, 1, 2, 3). To account for potential residual con-
founding by smoking, we ran models incorporating more de-
tailed smoking variables,11 including current status, number 
of cigarettes smoked, smoking duration, and time since quit-
ting. As this further adjustment did not change the results, 
only the results from the original models are presented. Race/
ethnicity‐stratified analyses were performed to evaluate the 
relationships between risk factors and pancreatic cancer in 
each subpopulation. Tests of heterogeneity were conducted 
using models with cross‐product terms for each risk factor 
and race/ethnicity.
Population attributable fractions (PAF) were calculated 
for risk factors positively associated with pancreatic cancer 
using the method developed for cohort studies.12 This method 
calculates the PAF and 95% confidence intervals for various 
risk behavior modifications across specified follow‐up time 
intervals, while accounting for other risk factors and mortal-
ity as a competing risk. We calculated the PAFs associated 
with modifications in risk factors including BMI (≥25 to 
<25, ≥30 to <25 kg/m2), smoking (current to never), diabe-
tes (yes to no), and red meat intake (second/third/fourth quar-
tiles to first quartile). We also calculated PAFs for all of the 
aforementioned risk factors combined. Population attribut-
able fractions were calculated for the entire cohort as well as 
for each racial/ethnic group over a 20‐year follow‐up period.
Schoenfeld residuals were used to verify the proportional 
hazards assumption and Martingale and deviance residuals 
were assessed to determine model fit.13 Analyses were con-
ducted using SAS 9.3 (Cary, NC) and reported P‐values are 
two‐sided.
3 |  RESULTS
This study consisted of 184,559 at‐risk individuals (100,969 
females and 83,590 males). The largest racial/ethnic group 
was Japanese Americans (29.0%), followed by European 
Americans (25.1%), Latino Americans (22.0%), African 
Americans (16.7%), and Native Hawaiians (7.3%). The 
average age at cohort entry was 59.9 (standard deviation 8.8). 
Approximately half of the participants were nonsmokers 
(44.9%) and non‐alcohol users (51.2%), while nearly 60% of 
the cohort was either overweight or obese. In addition, 11.7% 
of participants had diabetes while only 1.7% had a family his-
tory of pancreatic cancer (Table 1).
The prevalence of risk factors differed across racial/eth-
nic groups. Family history of pancreatic cancer  was slightly 
more prevalent in Japanese Americans (2.3%) compared to the 
other subpopulations. Diabetes was less common in European 
Americans (5.9%) and more common in Japanese Americans 
(10.5%), Native Hawaiians (14.8%), African Americans 
(15.7%), and Latino Americans (15.7%). African Americans, 
Native Hawaiians, and Latino Americans were more likely to 
have BMI ≥25 kg/m2. Current smoking was more prevalent in 
Native Hawaiians (22.6%) and African Americans (22.5%), and 
less prevalent among Japanese Americans (11.8%) and Latino 
Americans (14.2%). Alcohol use was more commonly observed 
in European Americans (65.2%), while red meat intake (highest 
quartile) was greater among African Americans (27.9%), Latino 
Americans (30.8%), and Native Hawaiians (32.5%) (Table 1).
There were 1,532 incident cases of pancreatic cancer over 
an average follow‐up period of 16.9 years. Age‐standardized 
pancreatic cancer incidence rates were lowest in European 
Americans and highest in Native Hawaiians. Compared to 
European Americans (41.3 per 100,000 person‐years), Native 
Hawaiians (73.4), Japanese Americans (56.8), and African 
Americans (52.7) all had higher rates (P < 0.01). There was no 
difference in the incidence rates between Latino Americans 
(42.0) and European Americans (P = 0.87) (Table 2).
We also detected an increased risk of pancreatic cancer 
for Native Hawaiians, Japanese Americans, and African 
Americans in our Cox models (Table 3). When only ad-
justing for age and sex, Native Hawaiians (RR 1.75, 95% 
CI 1.42‐2.15), Japanese Americans (RR 1.32, 95% CI 
1.15‐1.52), and African Americans (RR 1.34, 95% CI 
1.13‐1.57) were all at greater risk for pancreatic cancer 
compared to European Americans. These risks remained el-
evated after adjusting for family history of pancreatic can-
cer, diabetes, BMI, smoking, alcohol, and red meat intake. 
Native Hawaiians had a 60% increased risk (RR 1.60, 95% 
Race/ethnicity N Cases Person‐years
Age‐adjusted 
incidence ratea Pb
European American 46,356 306 784,877.9 41.3  
African American 30,731 277 488,746.5 52.7 <0.01
Native Hawaiian 13,412 128 221,361.6 73.4 <0.001
Japanese American 53,429 545 922,177.0 56.8 <0.0001
Latino American 40,631 276 697,674.8 42.0 0.87
aIncidence rate per 100,000 person‐years, age‐standardized to US Census 2000 standard population, left trun-
cated at age 45. 
bFrom a test comparing incidence rates to European Americans based on standardized rate ratios. 
T A B L E  2  Age‐adjusted incidence 
rates of pancreatic cancer, by race/ethnicity
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CI 1.30‐1.98), Japanese Americans had a 33% increased risk 
(RR 1.33, 95% CI 1.15‐1.54), and African Americans had a 
20% increased risk (RR 1.20, 95% CI 1.01‐1.42) compared to 
European Americans (Table 3). Native Hawaiians also had a 
higher risk compared to African Americans (P = 0.01), but 
not compared to Japanese Americans (P = 0.06). The risks 
for Japanese Americans and African Americans were not dif-
ferent from each other (P = 0.21).
T A B L E  3  Associations of race/ethnicity and various risk factors and pancreatic cancer risk
Risk factor Cases Person‐years
Minimally adjusteda 
RR (95% CI)
Fully adjustedb 
RR (95% CI)
Race/ethnicity
European American 306 784,877.9 1 (ref) 1 (ref)
African American 277 488,746.5 1.34 (1.13‐1.57) 1.20 (1.01‐1.42)
Native Hawaiian 128 221,361.6 1.75 (1.42‐2.15) 1.60 (1.30‐1.98)
Japanese American 545 922,177.0 1.32 (1.15‐1.52) 1.33 (1.15‐1.54)
Latino American 276 697,674.8 0.95 (0.81‐1.12) 0.90 (0.76‐1.07)
Family history of pancreatic cancer
No 1,478 3,060,983.6 1 (ref) 1 (ref)
Yes 54 53,854.1 1.93 (1.47‐2.53) 1.97 (1.50‐2.58)
Diabetes
No 1,316 2,808,732.7 1 (ref) 1 (ref)
Yes 216 306,105.0 1.37 (1.18‐1.58) 1.32 (1.14‐1.54)
Body mass index (kg/m2)
<25 625 1,299,492.5 1 (ref) 1 (ref)
25‐30 599 1,203,354.1 1.09 (0.97‐1.23) 1.09 (0.97‐1.23)
≥30 308 611,991.0 1.27 (1.10‐1.47) 1.25 (1.08‐1.46)
ptrendc     <0.01 0.01
Smoking status, with pack‐year information
Never 679 1,459,583.7 1 (ref) 1 (ref)
Past <20 pack‐years 414 908,445.2 1.00 (0.88‐1.13) 0.99 (0.87‐1.12)
Past ≥20 pack‐years 152 279,328.2 1.02 (0.85‐1.22) 0.97 (0.81‐1.17)
Current <20 pack‐years 140 264,554.3 1.44 (1.20‐1.74) 1.43 (1.19‐1.73)
Current ≥20 pack‐years 147 202,926.3 1.77 (1.47‐2.13) 1.76 (1.46‐2.12)
ptrendc     <0.0001 <0.0001
Alcohol use (g/day)
None 820 1,570,115.6 1 (ref) 1 (ref)
<24 544 1,197,773.7 0.97 (0.87‐1.09) 0.98 (0.88‐1.11)
24‐48 108 221,918.6 1.03 (0.83‐1.26) 1.00 (0.81‐1.24)
>48 60 125,029.8 0.99 (0.76‐1.30) 0.95 (0.73‐1.25)
ptrendc     0.94 0.66
Red meat intake (g/kcal/day)
Q1 (0‐14.1) 347 790,241.8 1 (ref) 1 (ref)
Q2 (14.1‐23.9) 427 778,626.9 1.26 (1.10‐1.46) 1.23 (1.06‐1.42)
Q3 (23.9‐35.2) 384 779,380.7 1.20 (1.03‐1.38) 1.13 (0.97‐1.31)
Q4 (35.2‐216.5) 374 766,588.4 1.29 (1.11‐1.49) 1.17 (1.00‐1.36)
ptrendc     <0.01 0.11
aAge and sex as strata variables, race as covariate. 
bAge and sex as strata variables, race, smoking with pack‐year information, alcohol use, BMI, family history of pancreatic cancer, diabetes, and red meat intake as 
covariates. 
cFrom a model treating exposure as continuous variable coded as consecutive numbers (eg, 1, 2, 3). 
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We observed higher pancreatic cancer risk associated 
with family history of pancreatic cancer (RR 1.97, 95% CI 
1.50‐2.58), diabetes (RR 1.32, 95% CI 1.14‐1.54), BMI 
≥30  kg/m2 (RR 1.25, 95% CI 1.08‐1.46), current smoking 
(<20 pack‐years: RR 1.43, 95% CI 1.19‐1.73; ≥20 pack‐
years: RR 1.76, 95% CI 1.46‐2.12), and red meat (Q4 vs Q1: 
RR 1.17, 95% CI 1.00‐1.36) (Table 3).
While there was no heterogeneity across race/ethnicity, 
the associations of these risk factors appeared stronger for 
particular subgroups (Table 4). The association between 
first‐degree family history of pancreatic cancer and risk 
of pancreatic cancer was greatest for Japanese Americans 
(RR 2.43, 95% CI 1.69‐3.50) and African Americans (RR 
2.18, 95% CI 1.07‐4.41), while diabetes had the largest in-
fluence in Native Hawaiians (RR 2.01, 95% CI 1.30‐3.12). 
BMI ≥30 kg/m2 had the greatest association for Japanese 
Americans (RR 1.79, 95% CI 1.30‐2.45), followed by 
Latino Americans (RR 1.36, 95% CI 0.96‐1.92), and 
Native Hawaiians (RR 1.28, 95% CI 0.79‐2.08). Current 
smoking status had the strongest association with pan-
creatic cancer among Japanese Americans (RR 1.92 95% 
CI 1.48‐2.49) and African Americans (RR 1.67, 95% CI 
1.22‐2.31). Likewise, greater pack‐years of smoking had 
a larger impact for Japanese Americans (current smoking 
≥20 pack‐years: RR 2.28, 95% CI 1.67‐3.12) and African 
Americans (current smoking ≥20 pack‐years: RR 1.85, 
95% CI 1.17‐2.90). Red meat had the strongest influence 
in African Americans (highest vs lowest quartile: RR 1.48, 
95% CI 1.03‐2.14).
From the PAF calculations, diabetes, BMI ≥25, current 
smoking, and red meat intake altogether accounted for one fifth 
of pancreatic cancer cases (PAF 21.57, 95% CI 12.37‐29.81). 
Across racial/ethnic groups, this combination of risk factors 
explained similar proportions of cases in Latino Americans 
(32.21, 95% CI 5.94‐51.15), African Americans (29.48, 
95% CI 3.73‐48.34), and Japanese Americans (19.75, 95% 
CI 5.22‐32.06), but lower proportions of cases in European 
Americans (9.00, 95% CI −12.20 to 26.19) and Native 
Hawaiians (7.10, 95% CI −46.51 to 41.10). When evaluating 
the individual risk factors, about 8% of cases could be at-
tributed to BMI ≥25 (PAF 7.59, 95% CI 1.41‐13.37) and 3% 
to BMI ≥30 (PAF 3.36, 95% CI 0.55‐6.09). These estimates 
were similar for Japanese Americans (BMI ≥25: PAF 8.63, 
95% CI 1.59‐15.16; BMI ≥30 PAF 3.53, 95% CI 0.97‐6.02), 
but were not statistically significant for the other race/ethnic-
ity subgroups (data not shown). In addition, current smoking 
explained approximately 4% of cases for the whole cohort 
(PAF 4.19, 95% CI 1.67‐6.64) and about 6% of cases among 
Japanese Americans (6.29, 95% CI 2.64‐9.80). However, the 
PAFs for current smoking were not significant for European 
Americans (1.46, 95% CI −4.56 to 7.13), African Americans 
(6.56, 95% CI −0.84 to 13.42), Native Hawaiians (3.37, 
95% CI −7.49 to 13.14), or Latino Americans (1.00, 95% CI R
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−4.44 to 6.16). For red meat, about 10% of the cases could 
be prevented (PAF 9.97, 95% CI 0.99‐18.15) if those in the 
upper three quartiles of red meat consumption reduced their 
intake to the first quartile. This decrease was over doubled 
among African Americans (PAF 26.40, 95% CI 5.73‐42.54), 
but was not statistically significant for the other populations. 
There was no decrease in pancreatic cancer burden associated 
with a modification in diabetes status for the entire cohort 
(PAF 1.06, 95% CI −1.01 to 3.10) or within any subgroups.
4 |  DISCUSSION
In this study, we evaluated differences in pancreatic cancer 
incidence and risk factor associations across five racial/ethnic 
groups in the MEC. We observed higher rates of pancreatic 
cancer among African Americans, Native Americans, and 
Japanese Americans, but no difference for Latino Americans, 
compared to European Americans. While these disparities 
did not seem to be fully explained by the distribution and 
effects of risk factors across race/ethnicity, a substantial frac-
tion of pancreatic cancers in our cohort (20%) could be attrib-
uted to smoking, adiposity, and red meat intake.
African Americans have had historically higher rates of 
pancreatic cancer incidence compared to whites.14 While 
risk factors such as obesity, diabetes, and smoking are more 
prevalent among African Americans, past research has sug-
gested that they do not fully explain the differences in pan-
creatic cancer incidence.15,16 Our findings provide additional 
support for this disparity, as African Americans had a 20% 
greater risk of pancreatic cancer compared to European 
Americans even after adjusting for known risk factors. Thus, 
other factors not reflected in our analysis may instead account 
for these differences in incidence. In particular, current ev-
idence has suggested that African Americans may perhaps 
have higher exposure to carcinogens compared to European 
Americans. This is supported by research suggesting that 
African Americans are slower metabolizers of cigarette 
smoke toxins17 and are more likely to have the risky rapid 
phenotype of the N‐acetyltransferase‐1 enzyme,18 which pro-
motes the bioactivation of arylamine carcinogens.19 Smoking 
and dietary preferences among this population may also con-
tribute to elevated carcinogen exposure. African Americans 
tend to smoke menthol cigarettes,17,20 which facilitate deeper 
inhalation and penetration of harmful tobacco products,21 
and consume higher amounts of well‐done and pan‐fried 
meats,18,22 which have increased levels of heterocyclic amines 
and polycyclic aromatic hydrocarbons.23 These issues could 
thus potentially explain why the impact of smoking and red 
meat were stronger for African Americans in our analyses. 
In addition, higher rates of pancreatic cancer among African 
Americans may be attributed to differences in genetic sus-
ceptibility. As there is currently a lack of studies examining 
genetics and pancreatic cancer in this population, our results 
may provide an indication of which specific genetic markers 
to investigate in future studies.
Pancreatic cancer incidence rates have also been consis-
tently elevated among Native Hawaiians according to the 
Hawaii Tumor Registry and other SEER registries.24,25 In our 
cohort, Native Hawaiians had the greatest disparity among 
all race/ethnicity groups, with nearly double the age‐adjusted 
incidence rate and about a 60% greater relative risk of pan-
creatic cancer compared to European Americans after risk 
factor adjustment. This difference in incidence can perhaps 
be explained by race‐specific variations in the susceptibility 
and severity of diabetes, which was a strong independent risk 
factor among Native Hawaiians in our analysis. Literature 
has shown that there is a disproportionate burden of diabetes 
among Native Hawaiians, as both the prevalence and risk of 
diabetes is much higher for Native Hawaiians compared to 
European Americans.26-28 There is also evidence suggesting 
that diabetes may be more critical and advanced in this pop-
ulation. Native Hawaiians are more frequently hospitalized 
for diabetes29 and have a greater likelihood of experiencing 
diabetes‐related complications and mortality.26,30 In addition, 
Native Hawaiians are more likely to have poorer glycemic 
control and elevated blood glucose levels,31,32 which have 
been observed to be associated with pancreatic cancer.33 
Future studies investigating diabetes severity and pancre-
atic cancer across race/ethnicity groups would be valuable 
in understanding this increased incidence among Native 
Hawaiians.
We found that Japanese Americans had both a higher in-
cidence rate and relative risk for pancreatic cancer compared 
to European Americans. While not previously highlighted, 
recent incidence data (2009‐2013) from the Hawaii Tumor 
Registry showed that Japanese  individuals had greater age‐
adjusted incidence rates compared to European Americans.24 
We also observed that the relative risk for Japanese Americans 
remained practically unchanged between our minimally and 
fully adjusted models, indicating that our covariates did not 
explain much of the disparity. However, the fact that family 
history of pancreatic cancer was a stronger risk factor among 
Japanese Americans than among European Americans sug-
gests that genetics may play a more substantial role in de-
fining risk between race/ethnicity groups. This hypothesis 
is supported by a previous genome‐wide association study 
(GWAS) in Japanese individuals, which identified three pan-
creatic cancer susceptibility loci that were not observed to 
be associated with risk in prior GWAS studies of individu-
als of European ancestry.34-36 A recent GWAS meta‐analysis 
of three Japanese studies further found a genetic risk marker 
in GP2 that is also distinct to this population.37 In addition, 
non‐O blood alleles, which are associated with pancreatic 
cancer,38 appear to be more prevalent in Japanese individuals 
compared to Europeans.39
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Our analysis did not detect any difference in pancreatic 
cancer incidence and risk between Latino Americans and 
European Americans. Additionally, our race/ethnicity‐strat-
ified models showed that the patterns of associations for 
each risk factor and pancreatic cancer were similar between 
European and Latino Americans. Data from SEER and the 
CDC's National Program of Cancer Registries have reported 
similar age‐standardized incidence rates between Hispanic 
and white females, but slightly lower rates for Hispanic men 
compared to white men.40,41 It is possible that the decreased 
rates for Hispanic males may be attributed to the lower prev-
alence of smoking in this population.42
To our knowledge, this is the first study to calculate 
PAFs for pancreatic cancer risk factors across race/ethnic-
ity using a formula that accounts for the competing risk of 
death. Our PAF estimates for current smoking (1%‐7%) are 
lower than the PAFs for smoking reported in two prior stud-
ies (15%‐42%) examining pancreatic cancer risk factors in 
whites and blacks.6,16 However, it may be difficult to make 
direct comparisons with these studies because the authors 
used formulas that did not consider follow‐up time or mor-
tality and did not calculate separate PAFs for current smok-
ing alone. In addition, PAF calculations that ignore mortality 
tend to overestimate the PAF when the follow‐up period is 
long and the risk factor in question is strongly associated with 
mortality.43 As the average follow‐up time was 16.9 years and 
smoking had a greater influence on mortality than pancreatic 
cancer in our cohort, using a formula that addressed censor-
ing due to death was more appropriate and provided a more 
accurate PAF estimation.
The strengths of our study include the prospective de-
sign and large, ethnically diverse population. This permit-
ted us to evaluate disparities in incidence and the influence 
of risk factors across several race/ethnicity groups, partic-
ularly minority populations that have been understudied. 
Furthermore, calculating PAFs using a formula designed 
specifically for cohort studies that controlled for competing 
risk of death and other risk factors provided a more unbi-
ased PAF estimate compared to previous studies. However, 
as a number of risk factors were assessed by self‐report, 
the accuracy of some data elements may have been influ-
enced by social desirability bias. Since the baseline ques-
tionnaire was administered prior to case identification, we 
expect any misclassification to be nondifferential and bias 
our results toward the null. In addition, we used sociocul-
tural categories of race/ethnicity, which does not fully cap-
ture all variation in risk associated with genetic ancestry. 
Incorporating genetic data, as well as biomarker or imaging 
information to assess pancreatic fat (an emerging risk fac-
tor44), could have perhaps further accounted for some of 
the disparities between populations.
This study provided a comprehensive assessment of the 
incidence and known risk factors for pancreatic cancer across 
multiple racial/ethnic populations. Our findings suggest that 
the racial disparities in pancreatic cancer incidence are not 
fully explained by the interethnic differences in the distribu-
tion and effects of these mainly environmental risk factors. 
Residual risk in pancreatic cancer incidence may in fact be 
explained by other genetic and biological factors. Thus, fu-
ture studies should consider more detailed evaluations that 
incorporate both behavioral and genetic data to further eluci-
date these discrepancies between race/ethnicity groups.
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